Oncology Coding Break – Hematopoietic Malignancies

Oncology, Oncology Coding Break, Registry Education

<a href="https://www.registrypartners.com/author/heather-donohue/" target="_self">Heather Donohue</a>

Heather Donohue

Educator & Internship Program Manager

Published/Updated Date: December 23, 2024

This highly anticipated session offers a deep dive into hematopoietic malignancies, with a comprehensive exploration of myeloproliferative and lymphoid lineage neoplasms. The presentation begins by covering essential anatomy and medical terminology, designed to simplify the process of navigating complex pathology reports. To support you further, we’ve provided a Glossary of Terms as a convenient reference for tackling these challenging cases.

The session guides participants through Myeloproliferative Neoplasms (MPNs) as well as Chronic and Acute Leukemias, providing a thorough understanding from A to Z. By the end, you’ll gain the confidence and expertise needed to accurately abstract these neoplasms in your practice.

Thank you to everyone who joined us live! If you missed the session or would like additional resources, you can download the following:

Related

Why Oncology Programs Can’t Afford Data Gaps

Why Oncology Programs Can’t Afford Data Gaps

Every important decision an oncology program makes depends on data. Cancer committees review quality measures to evaluate program performance. Physicians use registry reports to monitor treatment patterns and outcomes. Hospital leaders rely on registry data to guide...

Breaking the Cycle of “Keeping Up” in Registry Management

Breaking the Cycle of “Keeping Up” in Registry Management

For many healthcare organizations, registry operations become centered on keeping pace with today's work instead of improving how the work gets done. Production continues, and reporting requirements are met, but there is rarely enough time to evaluate workflows....

The Hidden Cost of Inefficient Cancer Registry Workflows

The Hidden Cost of Inefficient Cancer Registry Workflows

Healthcare organizations depend on cancer registry data to evaluate outcomes, monitor quality, support research, meet accreditation requirements, and guide strategic decision-making. The value of that data depends on its accuracy, completeness, and timeliness, making...

Stay in Touch

Get our latest articles, registry insights, and company news straight to your inbox.

This field is for validation purposes and should be left unchanged.